Oncopeptides AB

36
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009414576
SEK
1.47
0.03 (2.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
71.00
31.00
35.00
8.00
118.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
71.00
31.00
35.00
8.00
118.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
140.00
118.00
108.00
500.00
398.00
Operating Expenses
23.00
12.00
5.00
0.00
0.00
1.00
General and Administration Expenses
194.00
191.00
180.00
131.00
856.00
639.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
299.00
321.00
294.00
359.00
1,600.00
1,520.00
Operating Profit (PBDIT) excl Other Income
-228.00
-289.00
-259.00
-351.00
-1,482.00
-1,520.00
Other Income
4.00
17.00
16.00
14.00
68.00
-70.00
Operating Profit (PBDIT)
-224.00
-261.00
-231.00
-319.00
-1,392.00
-1,576.00
Interest
23.00
12.00
5.00
0.00
0.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
9.00
11.00
17.00
21.00
14.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-248.00
-284.00
-248.00
-337.00
-1,421.00
-1,592.00
Provision for Tax
1.00
0.00
0.00
0.00
8.00
2.00
Profit After Tax
-249.00
-284.00
-249.00
-337.00
-1,430.00
-1,594.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-1.10
-1.52
-1.75
-2.60
-12.04
-16.21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 124.72% vs -10.14% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 20.95% vs -11.71% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 85.80% vs 118.81% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 12.31% vs -14.25% in Dec 2024

Compare Profit and Loss Results of Oncopeptides AB
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
No of Months
12
12
Operating Income
71.00
152.00
-81.00
-53.29%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
71.00
152.00
-81.00
-53.29%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
23.00
15.00
8.00
53.33%
General and Administration Expenses
194.00
29.00
165.00
568.97%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
299.00
183.00
116.00
63.39%
Operating Profit (PBDIT) excl Other Income
-228.00
-31.00
-197.00
-635.48%
Other Income
4.00
2.00
2.00
100.00%
Operating Profit (PBDIT)
-224.00
-13.00
-211.00
-1,623.08%
Interest
23.00
15.00
8.00
53.33%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
14.00
-14.00
-100.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-248.00
-43.00
-205.00
-476.74%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
-249.00
-46.00
-203.00
-441.30%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-1.1
0.0836
-1.18
-1,415.79%
Profit And Loss - Net Sales
Net Sales 71.12 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 124.72% vs -10.14% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -228.82 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.95% vs -11.71% in Dec 2024

Profit And Loss - Interest
Interest 23.52 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 85.80% vs 118.81% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax -249.59 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 12.31% vs -14.25% in Dec 2024